Brief: LianBio Announces Results From Phase 3 EXPLORER-CN Trial Of Mavacamten Presented At The European Society Of Cardiology Congress

LianBio

28/08/2023 21:34

Aug 28 (Reuters) - LianBio  LIAN.O :
    * LIANBIO ANNOUNCES RESULTS FROM PHASE 3 EXPLORER-CN TRIAL
OF
MAVACAMTEN PRESENTED AT THE EUROPEAN SOCIETY OF CARDIOLOGY
CONGRESS AND SIMULTANEOUS PUBLICATION IN JAMA CARDIOLOGY
    * LIANBIO - STUDY CONFIRMS PREVIOUSLY ESTABLISHED EFFICACY
OF
MAVACAMTEN CAN BE EXTENDED TO CHINESE PATIENTS

Source text for Eikon:  ID:nGNX78XhZ4 
Further company coverage:  LIAN.O 

 ((Reuters.Brief@thomsonreuters.com;))